# Ongoing Lung Decline With Age Intensified Response

> **NCT07676435** · PHASE2 · RECRUITING · sponsor: **Cedars-Sinai Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Age-Related Lung Function Decline

## Interventions

- **DRUG:** Fisetin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07676435
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-17
- **Primary completion:** 2027-06-16
- **Final completion:** 2027-07-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07676435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07676435, "Ongoing Lung Decline With Age Intensified Response". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07676435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*